| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2009 | US7521570 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
| 04/21/2009 | US7521569 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities |
| 04/21/2009 | US7521563 Hydroxamic acid derivative and medicine containing the same as active ingredient |
| 04/21/2009 | US7521561 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/21/2009 | US7521553 Crystalline forms of lamotrigine |
| 04/21/2009 | US7521481 administering to subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof; for treating or preventing condition of central or peripheral nervous system or systemic organ associated with a disorder in protein folding or aggregation, or amyloid formation |
| 04/21/2009 | US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor |
| 04/21/2009 | US7521479 Administering chaotropic agent |
| 04/21/2009 | US7521478 Antitumor agents; synthetic derivatives equivalent to marine polyketide derived components isolated from bryozoan Myriapora truncata; removing protecting groups from intermediates |
| 04/21/2009 | US7521477 Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same |
| 04/21/2009 | US7521476 Aminoacetonitrile derivatives suitable for controlling parasites |
| 04/21/2009 | US7521475 Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof |
| 04/21/2009 | US7521474 For blocking cellular proliferation, treatment of cancer/fungal infections, controlling spoilage of food, and in cosmetics |
| 04/21/2009 | US7521473 Inhibitors of protein tyrosine phosphatase 1B |
| 04/21/2009 | US7521472 Crystal of two-ring heterocyclic sulfonamide compound |
| 04/21/2009 | US7521471 CB1cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 04/21/2009 | US7521470 Factor Xa inhibitors |
| 04/21/2009 | US7521469 E.g., (5R,8R,11S)-5-benzyl-6-hydroxy-11-(1H-indol-3-ylmethyl)-3,9-dioxo-1-phenyl-8-[(3-phenyl-5-isoxazolyl)methyl]-2-oxa-4,10-diaza-6-phosphadodecan-12-oic Acid 6-oxide; simultaneously inhibit angiotensin converting enzyme and endothelin converting enzyme; treatment of arterial hypertension |
| 04/21/2009 | US7521468 Administering phenolic derivatives including 6-methoxy-2,3-benzoxazolinone (6-MBOA), benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides; antiarthritic, antidiabetic, and hypoglycemic agents; sleep disorders, fibromyalgia; monocotyledon plant extracts |
| 04/21/2009 | US7521467 Administering phenolic derivatives including 6-methoxy-2,3-benzoxazolinone (6-MBOA), benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides; antiarthritic, antidiabetic, and hypoglycemic agents; sleep disorders, fibromyalgia; monocotyledon plant extracts |
| 04/21/2009 | US7521465 thiazolidin-2,4-diones or -oxazolidin-2,4-diones or thiones; obesity, inflammation, autoimmune diseases (multiple sclerosis, rheumatoid arthritis); increase the leptin level; no liver toxicity; inhibits TNF- alpha , IL-1, IL-6, IL-1 beta and cyclooxygenase COX-2; no affinity for PPAR-g; non-adipogenic. |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521463 Immunomodulatory compounds |
| 04/21/2009 | US7521462 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
| 04/21/2009 | US7521460 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor |
| 04/21/2009 | US7521459 Method for treating damaged skin |
| 04/21/2009 | US7521458 Spiropiperidylrifamycins for the treatment of mycobacterial infections |
| 04/21/2009 | US7521457 Pyrimidines as PLK inhibitors |
| 04/21/2009 | US7521456 Antiproliferative agents; anticancer agents; Erlotinib mesylate |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521454 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521452 Preparation of pharmaceutical salts of piperazine compounds |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521449 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof |
| 04/21/2009 | US7521448 N-substituted benzimidazolyl c-Kit inhibitors |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521446 4-({8-[(2,6-Difluorophenyl)amino]-9-cyclopentylpurin-2-yl}amino) trans-cyclohexan-1-ol; mitogen-activated protein (tyrosine) kinase inhibitor; anticarcinogenic, antiinflammatory, analgesic agent, cardiovascular disease, renal disease, autoimmune condition, macular degeneration, pulmonary hypertension |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521444 Enzyme inhibitors; interferons; interleukins; cyclosporins |
| 04/21/2009 | US7521443 3,8-Diazabicyclo[3.2.1]octane-3-carboxylic acid, 8-[[8-cyclohexyl-5-[[[(dimethylamino)sulfonyl]amino]carbonyl]-1,12b-dihydro-11-methoxycycloprop[d]indolo[2,1-a][2]benzazepin-1a(2H)-yl]carbonyl]-, phenylmethyl ester; RNA polymerase inhibitor; liver disease, including cirrhosis and hepatocellular carcinoma |
| 04/21/2009 | US7521442 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 04/21/2009 | US7521441 8-Cyclohexyl-1,1a,2,12b-tetrahydro-1a-(4-morpholinylcarbonyl)-cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxylic acid, methyl ester; RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease, including cirrhosis and hepatocellular carcinoma |
| 04/21/2009 | US7521440 Targeted oxidative therapeutic formulation |
| 04/21/2009 | US7521439 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 04/21/2009 | US7521438 Allergies,chronic obstructive airway disorders (COPD), e.g. bronchial asthma, chronic obstructive bronchitis, pulmonary emphysema with reversible obstruction, bronchial asthma and other bronchial disorders; side effect reduction |
| 04/21/2009 | US7521437 7-phenyl-substituted tetracycline compounds |
| 04/21/2009 | US7521436 Modified phosphocalcic compound, injectable composition containing same |
| 04/21/2009 | US7521435 Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same |
| 04/21/2009 | US7521434 Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them |
| 04/21/2009 | US7521433 Complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/21/2009 | US7521432 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging |
| 04/21/2009 | US7521431 Compositions and methods for siRNA inhibition of HIF-1 alpha |
| 04/21/2009 | US7521430 N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter |
| 04/21/2009 | US7521429 each case in free form or in salt form; pesticidal compositions in which the active ingredient has been selected from those compounds and their tautomers; and a method of controlling pests using those compositions are described.** Image-1 |
| 04/21/2009 | US7521428 2',4'',13-Tri-O-benzoyl-8,9-Anhydro-pseudoerythromycin A 6,9-hemiketal; 2'-O-acetyl-4''-O-benzenesulfonyl-12,13-epoxy-8,9-Anhydro-pseudoerythromycin A 6,9-hemiketal; 3'-de-N-methyl-3'-N-{2-amino-(3'-de-N-methyl-erythromycin A)}ethyl-erythromycin A; reducing frequency of appearence of resistant fungus |
| 04/21/2009 | US7521418 When used in combination with glycopeptide antibacterial agent, the amount of polyene macrolide antifungal agent needed to treat a fungal infection is reduced thereby resulting in fewer side effects |
| 04/21/2009 | US7521417 Method and apparatus for preparing an acellular red blood cell substitute |
| 04/21/2009 | US7521414 Polyene-polyol structure; anticancer agents |
| 04/21/2009 | US7521240 Chromosome-based platforms |
| 04/21/2009 | US7521239 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521212 Method for producing oligopolysaccharides |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521191 siRNA targeting connexin 43 |
| 04/21/2009 | US7521177 Contacting the sample with a flavivirus antigen,produced by expressing a transcriptional unit encoding a Japanese encephalitis virus (JEV) signal sequence and an immunogenic flavivirus antigen of a flavivirus; detecting an increase in antigen/antibody complex formation |
| 04/21/2009 | US7521175 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/21/2009 | US7521072 Tablet form which is palatable; soluble, which do not significantly increase in viscosity or gel when exposed to water or other liquids, yet possess the desirable organoleptic characteristics |
| 04/21/2009 | US7521068 For pulmonary and nasal drug administration |
| 04/21/2009 | US7521066 Administering non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect and anticancer agent |
| 04/21/2009 | US7521065 Compositions for the treatment and prevention of cancer |
| 04/21/2009 | US7521064 Insertion into vagina; prevention, therapy for infections |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | US7521052 Administering an effective amount of an anti-IL-6 receptor antibody (anti-IL-6R antibody) and an effective amount of methotrexate (MTX) for therapy of rheumatoid arthritis |
| 04/21/2009 | US7521042 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant |
| 04/21/2009 | US7521041 Biphenyl-2-ylcarbamic acid or biphenyl-2-yluurea derivatives for treatment of respiratory system disorders; chronic obstructive pulmonary disease, asthma; antihistamines, bronchodilator agents; side effect reduction |
| 04/21/2009 | CA2532330C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 04/21/2009 | CA2499329C Indole-3-carboxamides as glucokinase (gk) activators |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2384585C Hydrogels for orthopedic repair |
| 04/21/2009 | CA2377609C Programming ovulation |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2341050C Nucleic acid sequence for potentiating the expression of useful gene and method therefor |
| 04/21/2009 | CA2339147C Stabilized preparations of .beta.-lactam antibiotic |
| 04/21/2009 | CA2338358C Compounds and compositions for delivering active agents |
| 04/21/2009 | CA2336902C Topical compositions comprising an opioid analgesic and an nmda antagonist |
| 04/21/2009 | CA2320878C Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 04/21/2009 | CA2309038C Use of inhaled no as anti-inflammatory agent |
| 04/21/2009 | CA2299420C Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 04/21/2009 | CA2279184C Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine |
| 04/21/2009 | CA2260022C Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of a lim-kinase gene |
| 04/21/2009 | CA2231603C Chicken interleukin-15 and uses thereof |
| 04/21/2009 | CA2228038C 2(1h)-quinolone derivatives, their preparation and their use in therapy |
| 04/21/2009 | CA2225761C Difluoroprostaglandin derivatives and their use |
| 04/21/2009 | CA2221341C Submicron liposome suspensions obtained from preliposome lyophilizates |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation |